These observations underline the crucial importance of KIF2C in the progression of colorectal cancer, which might be a possible treatment target by using an antigen specific immunotherapy to stimulate the immunosuppressive environment by triggering a spontaneous CD4+ T cell response of the Th1-type in colorectal cancer [115]. This evidence concerns the gene CD4 and colorectal cancer.